期刊文献+

RARE介导的视黄酸可调控的IFN-α表达载体的构建与鉴定 被引量:5

Construction and identification of an IFN-α gene eukaryotic expression vector containing retinoic acid response element
下载PDF
导出
摘要 目的构建一个含视黄酸反应元件 ( RARE)的 IFN- α表达载体 ,使其在真核细胞内的表达受视黄酸 ( RA)的诱导。方法运用 DNA重组技术构建含有 4个 RARE重复序列的 IFN- α真核表达载体 ( p RARE4 - IFN- α) ,经酶切、PCR鉴定和测序确认后 ,用脂质体转染法使其转染 HL- 60细胞 (人早幼粒白血病细胞系 )、Bcap- 3 7和 MCF- 7细胞 (人乳腺癌细胞系 ) ,RA处理后 ,RT- PCR分析 IFN- α m RNA水平 ,EL ISA检测培养细胞上清中 IFN- α含量。结果 p RARE4 - IFN- α转染的 HL- 60、Bcap- 3 7和 MCF- 7细胞 ,IFN- α分泌量为 16~ 2 4 ng/ ( m L· 10 6 )细胞 ,而经 RA处理 2 4 h,IFN- α表达水平可增加 8~ 13倍 ,但经 RA处理 2 4 h的细胞 ,换无 RA的新鲜培养基继续培养 2 4 h后 ,IFN- α表达水平又下降到 2 5~ 3 4 ng/ ( m L· 10 6 )细胞。结论带有 RARE的 IFN- α表达载体转染细胞后 ,外源性 IFN- α基因的表达受 RA的诱导。 ObjectiveTo investigate the possibility of the expression of exogenous IFN-α gene mediated by retinoic acid(RA)through retinoic acid response element (RARE). Methods An IFN-α gene eukaryotic expression vector containing four copies of RARE(pRARE4-IFN-α)was constructed with recombinant DNA technique, identificated with restriction endonuc- lease digest and PCR and DNA sequence analysis, then transfected into the cells of HL-60,Bcap-37 and MCF-7 with liposome DOTAP. The expression of IFN-α gene was analyzed with RT-PCR and ELISA. Results ELISA showed that the pRARE4-IFN-α transfected HL-60, Bcap-37 and MCF-7 cells treated with RA for 24 hours produced 184,211 and 241 ng/(mL·10 6) cells of IFN-α compared with 21,16 and 24 ng/(mL·10 6) cells in untreated transfected cells respectively, as compared with 15 ng/(mL·10 6) cells in nontransfected HL-60 cells treated with RA for 24 hours.ConclusionOur study suggest that RA is able to induce the expression of exogenous IFN-α gene in cells transfected with pRARE4-IFN-α.
出处 《免疫学杂志》 CAS CSCD 北大核心 2001年第4期277-280,共4页 Immunological Journal
基金 国家自然科学基金资助项目 ( 3 9770 3 0 3 )
关键词 视黄酸 干扰素 高黄酸反应元件 表达载体 IFNΑ 药物治疗 肿瘤 retinoic acid interferon retinoic acid response element expression vector
  • 相关文献

参考文献2

  • 1Zhang R,Endocrinology,1999年,140卷,5期,2152页
  • 2Liu M,J Biol Chem,1996年,271卷,31723页

同被引文献23

  • 1Malone C, Schiltz P M, Nayak S K, et al. Combination interferon-alpha2a and 13-cis-retinoic acid enhances radiosensitization of human malignant glioma cells in vitro [J]. Clin Cancer Res, 1999, 5 ( 2 ):417 - 423.
  • 2Syljuasen R G, Belldegrun A, Tso C L, et al. Sensitization of renal carcinoma to radiation using alpha interferon (IFNA) gene transfection[J]. Radiat Res, 1997, 148(5): 443 -448.
  • 3Lenardo M J. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis[J]. Nature, 1991, 353(6347): 858-861.
  • 4Mason K A, Tofilon P J. Unexpected radiation protection with 13-cisretinoic acid plus interferon alpha-2a[J]. Cancer Chemother Pharmacol, 1994, 33(5): 435 -437.
  • 5Ivanov A A, Kuznetsov V P, Ulanova A M, et al. Therapeutic antiradiation properties of leukinferon[J]. Radiats Biol Radioecol, 1998, 38(1): 62 -70.
  • 6Broaddus W C, Liu Y, Steele L L, et al. Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction [J]. J Neurosurg, 1999, 91(6): 997- 1004.
  • 7Belka C, Marini P, Budach W, et al. Radiation-induced apoptosis in human lymphocytes and lymphoma cells critically relies on the up-regulation of CD95/Fas/APO-1 ligand[J]. Radiat Res, 1998, 149 (6):588 - 595.
  • 8Voehringer D W, Hirschberg D L, Xiao J, et al. Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis [J]. Proc Natl Acad Sci USA, 2000, 97(6): 2680 - 2685.
  • 9Slee E A, Keogh S A, Martin S J. Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c release[J]. Cell Death Differ, 2000, 7(6): 556 -565.
  • 10Park H S, Huh S H, Kim Y, et al. Selenite negatively regulates caspase-3 through a redox mechanism [J]. J Biol Chem, 2000, 275(12): 8487 -8491.

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部